1. Home
  2. XPL vs SPRO Comparison

XPL vs SPRO Comparison

Compare XPL & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XPL
  • SPRO
  • Stock Information
  • Founded
  • XPL 1984
  • SPRO 2013
  • Country
  • XPL United States
  • SPRO United States
  • Employees
  • XPL N/A
  • SPRO N/A
  • Industry
  • XPL Precious Metals
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • XPL Basic Materials
  • SPRO Health Care
  • Exchange
  • XPL Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • XPL 46.5M
  • SPRO 39.2M
  • IPO Year
  • XPL N/A
  • SPRO 2017
  • Fundamental
  • Price
  • XPL $0.61
  • SPRO $0.73
  • Analyst Decision
  • XPL Strong Buy
  • SPRO Buy
  • Analyst Count
  • XPL 2
  • SPRO 4
  • Target Price
  • XPL $1.60
  • SPRO $5.00
  • AVG Volume (30 Days)
  • XPL 62.5K
  • SPRO 200.5K
  • Earning Date
  • XPL 05-05-2025
  • SPRO 05-14-2025
  • Dividend Yield
  • XPL N/A
  • SPRO N/A
  • EPS Growth
  • XPL N/A
  • SPRO N/A
  • EPS
  • XPL N/A
  • SPRO N/A
  • Revenue
  • XPL N/A
  • SPRO $47,977,000.00
  • Revenue This Year
  • XPL N/A
  • SPRO N/A
  • Revenue Next Year
  • XPL N/A
  • SPRO N/A
  • P/E Ratio
  • XPL N/A
  • SPRO N/A
  • Revenue Growth
  • XPL N/A
  • SPRO N/A
  • 52 Week Low
  • XPL $0.54
  • SPRO $0.51
  • 52 Week High
  • XPL $0.98
  • SPRO $1.72
  • Technical
  • Relative Strength Index (RSI)
  • XPL 52.41
  • SPRO 51.21
  • Support Level
  • XPL $0.63
  • SPRO $0.51
  • Resistance Level
  • XPL $0.68
  • SPRO $0.78
  • Average True Range (ATR)
  • XPL 0.04
  • SPRO 0.09
  • MACD
  • XPL 0.01
  • SPRO 0.02
  • Stochastic Oscillator
  • XPL 63.93
  • SPRO 68.52

About XPL Solitario Resources Corp.

Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: